About
About IbogaBase
IbogaBase is an independent, educational reference about iboga, ibogaine, and related compounds — the plant, the molecules, the evidence, the risks, the law, and the cultures that have carried iboga for generations.
Who makes this
IbogaBase is maintained by Sean — an independent person, not a doctor, clinic, or company. He came to this subject through his own experience: first using ibogaine to recover from an addiction, and later through time spent in Misoko Bwiti ceremony. That experience is what motivated this reference. It is not a substitute for medical or scientific expertise, and nothing here should be read as personal testimony, encouragement, or advice.
How it is made
Sean uses AI tools to help gather, organize, and summarize published sources — studies, clinical trials, laws, news, and cultural scholarship. Every page is reviewed by a person before publication and linked back to its sources, so readers can check the original material themselves. The aim is a careful, well-sourced field reference, not opinion or persuasion.
What this site does and does not do
- It summarizes evidence, safety information, law, policy, and cultural context — always with sources.
- It does not provide dosing, treatment protocols, clinic or provider recommendations, or sourcing guidance.
- It is educational only. It is not medical or legal advice.
- It treats traditional and Bwiti knowledge with respect, and does not publish sacred or lineage-held detail.
Reader boundary
This is not medical advice or legal advice. Ibogaine remains Schedule I federally in the United States, is not FDA-approved as a treatment, and carries serious cardiac and interaction risks. Emergency, treatment, and legal decisions belong with qualified professionals and local emergency systems.
Corrections and contact
IbogaBase aims to be accurate and to correct mistakes openly. If you find an error, want to suggest a source, or are a knowledge holder with a concern about how cultural material is represented here, please write to hello@ibogabase.com.
Core distinctions
- Iboga
- Tabernanthe iboga and related Central African cultural, ecological, conservation, and stewardship contexts.
- Ibogaine
- A psychoactive indole alkaloid studied for opioid withdrawal, substance use, TBI-related symptoms, and other neuropsychiatric questions, with serious safety and legal constraints.
- Noribogaine
- A metabolite and drug-development focus. FDA permission for an investigational study is not FDA approval and does not establish safety or effectiveness.
- Analogs
- 18-MC, tabernanthalog, and related derivatives are tracked by molecule, sponsor, evidence type, and clinical status. They are not interchangeable with Iboga or Ibogaine.